Boston Scientific has reported data from the PROTECTED TAVR clinical trial of the SENTINEL Cerebral Protection System.
The SENTINEL device has been designed for capturing and removing the embolic debris stemming from transcatheter aortic valve replacement (TAVR) before it reaches brain and causes a stroke.
The PROTECTED TAVR trial is claimed to be the largest randomised TAVR trial to date.
